| Issue Date | Title | Author(s) |
| 15-Apr-2021 | Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS | Stek, C; Buyze, J; Menten, J; Schutz, C; Tinman, F, et al |
| 1-Mar-2021 | Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis | Du Bruyn, E; Ruzive, S; Lindestam Arlehamn, CS; Sette, A; Sher, AF, et al |
| 5-Oct-2022 | Prednisone for the prevention of tuberculosis-associated IRIS (randomized controlled trial): Impact on the health-related quality of life | Wouters, E; Stek, C; Swartz, A; Buyze, J; Schutz, C, et al |
| 13-Aug-2020 | Protocol for systematic review and meta-analysis: impact of statins as immune-modulatory agents on inflammatory markers in adults with chronic diseases | Sabeel, S; Motaung, B; Ozturk, M; Mukasa, S; Kengne, AP, et al |
| 12-Mar-2020 | The effect of HIV-associated tuberculosis, tuberculosis-IRIS, and prednisone on lung function | Stek, C; Allwood, B; Du Bruyn, E; Buyze, J; Schutz, C, et al |
| 1-Jan-2021 | Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19 | Wilkinson, R; |
| 1-Mar-2021 | Visualizing the dynamics of tuberculosis pathology using molecular imaging | Ordonez, AA; Tucker, EW; Anderson, CJ; Carter, CL; Ganatra, S, et al |